Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Pharmaceutics ; 16(1)2023 Dec 19.
Artigo em Inglês | MEDLINE | ID: mdl-38276483

RESUMO

Oral cancer (OC), characterized by malignant tumors in the mouth, is one of the most prevalent malignancies worldwide. Chemotherapy is a commonly used treatment for OC; however, it often leads to severe side effects on human bodies. In recent years, nanotechnology has emerged as a promising solution for managing OC using nanomaterials and nanoparticles (NPs). Nano-drug delivery systems (nano-DDSs) that employ various NPs as nanocarriers have been extensively developed to enhance current OC therapies by achieving controlled drug release and targeted drug delivery. Through searching and analyzing relevant research literature, it was found that certain nano-DDSs can improve the therapeutic effect of drugs by enhancing drug accumulation in tumor tissues. Furthermore, they can achieve targeted delivery and controlled release of drugs through adjustments in particle size, surface functionalization, and drug encapsulation technology of nano-DDSs. The application of nano-DDSs provides a new tool and strategy for OC therapy, offering personalized treatment options for OC patients by enhancing drug delivery, reducing toxic side effects, and improving therapeutic outcomes. However, the use of nano-DDSs in OC therapy still faces challenges such as toxicity, precise targeting, biodegradability, and satisfying drug-release kinetics. Overall, this review evaluates the potential and limitations of different nano-DDSs in OC therapy, focusing on their components, mechanisms of action, and laboratory therapeutic effects, aiming to provide insights into understanding, designing, and developing more effective and safer nano-DDSs. Future studies should focus on addressing these issues to further advance the application and development of nano-DDSs in OC therapy.

2.
Mol Med Rep ; 24(3)2021 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-34278470

RESUMO

Tissues have remarkable natural capabilities to regenerate for the purpose of physiological turnover and repair of damage. Adult mesenchymal stem cells (MSCs) are well known for their unique self­renewal ability, pluripotency, homing potential, paracrine effects and immunomodulation. Advanced research of the unique properties of MSCs have opened up new horizons for tissue regenerative therapies. However, certain drawbacks of the application of MSCs, such as the low survival rate of transplanted MSCs, unsatisfactory efficiency and even failure to regenerate under an unbalanced microenvironment, are concerning with regards to their wider therapeutic applications. The activity of stem cells is mainly regulated by the anatomical niche; where they are placed during their clinical and therapeutic applications. Crosstalk between various niche signals maintains MSCs in homeostasis, in which the WNT signaling pathway plays vital roles. Several external or internal stimuli have been reported to interrupt the normal bioactivity of stem cells. The irreversible tissue loss that occurs during infection at the site of tissue grafting suggests an inhibitory effect mediated by microbial infections within MSC niches. In addition, MSC­seeded tissue engineering success is difficult in various tissues, when sites of injury are under the effects of a severe infection despite the immunomodulatory properties of MSCs. In the present review, the current understanding of the way in which WNT signaling regulates MSC activity modification under physiological and pathological conditions was summarized. An effort was also made to illustrate parts of the underlying mechanism, including the inflammatory factors and their interactions with the regulatory WNT signaling pathway, aiming to promote the clinical translation of MSC­based therapy.


Assuntos
Células-Tronco Mesenquimais/metabolismo , Regeneração/fisiologia , Via de Sinalização Wnt/fisiologia , Cicatrização/fisiologia , Animais , Diferenciação Celular , Citocinas , Humanos , Imunomodulação , Transplante de Células-Tronco Mesenquimais , Células-Tronco Mesenquimais/patologia , Engenharia Tecidual
3.
J Oral Maxillofac Surg ; 79(10): 2147-2154, 2021 10.
Artigo em Inglês | MEDLINE | ID: mdl-34023287

RESUMO

PURPOSE: The survival benefit of postoperative adjuvant treatment (POAT) for stage II oral tongue squamous cell carcinoma (OTSCC) remains controversial. This large SEER-based study aims to establish a prognostic nomogram to visualize the overall survival of these patients and to aid in POAT decision making. PATIENTS AND METHODS: The cut-off points of age at diagnosis and examined lymph node number (ELN) were determined using the population-based data from the SEER database. Univariate and multivariate Cox hazards regression models were utilized to identify prognostic factors that were integrated into the establishment of the prognostic nomogram. Patients with stage II OTSCC were then stratified into 3 cohorts based on this nomogram. The survival benefit of POAT was evaluated in these cohorts. RESULTS: Age at diagnosis (with cutoff points of 50 and 75 years) and ELN (with cutoff points of 0 and 22) was significantly associated with the survival outcomes in patients with stage II OTSCC. After the multivariate analysis, 4 factors, including age at diagnosis, sex, ELN, and differentiation grade, were identified as independent prognostic factors. Additionally, a prognostic nomogram with these factors was constructed to predict overall survival and to stratify these patients. Only patients in the high-risk cohort could significantly benefit from postoperative adjuvant treatment. CONCLUSIONS: This prognostic nomogram could accurately predict the overall survival of stage II OTSCC patients after curative surgery. Notably, this model could also assist the decision-making of postoperative adjuvant treatment for patients with stage II OTSCC.


Assuntos
Carcinoma de Células Escamosas , Neoplasias de Cabeça e Pescoço , Neoplasias da Língua , Carcinoma de Células Escamosas/patologia , Carcinoma de Células Escamosas/cirurgia , Humanos , Estadiamento de Neoplasias , Nomogramas , Prognóstico , Programa de SEER , Carcinoma de Células Escamosas de Cabeça e Pescoço , Neoplasias da Língua/cirurgia
4.
Anticancer Agents Med Chem ; 17(9): 1234-1242, 2017.
Artigo em Inglês | MEDLINE | ID: mdl-26478521

RESUMO

BACKGROUND: 15,16-dihydrotanshinone I (DHTI), a lipophilic tanshinone extracted from Danshen root (Salvia miltiorrhiza Bunge), has been reported to function as an antitumor agent. However, its activity on osteosarcoma (OS), the most common primary malignant bone tumor, is unclear. OBJECTIVE: This study aimed to determine the effects of DHTI treatment on proliferation, apoptosis and migration of human OS cell line 143B and investigate the possible underlying molecular mechanisms. METHOD: Human cell line 143B was used as a model for investigation of the inhibitory effects of DHTI on osteosarcoma. Cell proliferation was evaluated by MTT assays, while cell cycle progression, apoptosis and cell migration were analyzed by flow cytometer, caspase activity assays and scratch migration assays. qRT-PCR and western blot were carried out to detect the expression levels of representative genes and proteins during physiological processes examined above. RESULTS: DHTI treatment inhibited the proliferation of 143B cells in a dose- and time-dependent manner through arresting cells in G1 phase by reducing the expression of cyclin D1, cyclin E1, CDK2, CDK4, CDK6, p-Rb, E2F1, SKP2 and increasing the expression of P53, P21cip1, P27kip1. In addition, DHTI induced apoptosis of 143B cells through caspase pathways to activate caspase-3, caspase-8, caspase-9, Bax, and PARP cleavage but reduce the expression of Bcl-2. Furthermore, DHTI treatment attenuated cell migration by down-regulating adhesion molecules VCAM-1 and ICAM-1. CONCLUSION: These findings suggest that DHTI could be a novel and efficient therapeutic candidate for OS treatment and further detailed investigation is warranted.


Assuntos
Antineoplásicos/farmacologia , Apoptose/efeitos dos fármacos , Neoplasias Ósseas/tratamento farmacológico , Osteossarcoma/tratamento farmacológico , Fenantrenos/farmacologia , Antineoplásicos/química , Neoplasias Ósseas/patologia , Movimento Celular/efeitos dos fármacos , Proliferação de Células/efeitos dos fármacos , Relação Dose-Resposta a Droga , Ensaios de Seleção de Medicamentos Antitumorais , Furanos , Humanos , Osteossarcoma/patologia , Fenantrenos/química , Quinonas , Relação Estrutura-Atividade , Células Tumorais Cultivadas
5.
Shanghai Kou Qiang Yi Xue ; 19(5): 530-3, 2010 Oct.
Artigo em Chinês | MEDLINE | ID: mdl-21161135

RESUMO

PURPOSE: To study the effect of Salvia Miltiorrhiza Bunge on the expression of osteoprotegerin (OPG) in cultured human periodontal ligament fibroblasts. METHODS: Primary culture of human periodontal ligament fibroblasts was established and the fifth passage cells were used in this study. Concentration-dependent effect of Salvia Miltiorrhiza Bunge on OPG mRNA and OPG protein secretion were determined by reverse transcription-polymerase chain reaction (RT-PCR) and enzyme linked immunosorbant assay (ELISA), respectively. The data were analyzed with SPSS15.0 software package. RESULTS: OPG mRNA expression was increased after 1 h exposure to various concentrations of Salvia Miltiorrhiza Bunge compared with the control group (P<0.05). OPG protein secretion was significantly increased after 12 h exposure to various concentrations of Salvia Miltiorrhiza Bunge compared with the control group (P<0.05). CONCLUSION: Salvia Miltiorrhiza Bunge can up-regulate the expression of OPG in cultured human periodontal ligament fibroblasts.


Assuntos
Osteoprotegerina , Ligamento Periodontal , Fibroblastos , Humanos , Ligante RANK , RNA Mensageiro , Salvia miltiorrhiza
6.
Shanghai Kou Qiang Yi Xue ; 16(4): 385-7, 2007 Aug.
Artigo em Chinês | MEDLINE | ID: mdl-17924023

RESUMO

PURPOSE: To assess the efficacy of intraoral open reduction of mandibular body fracture using titanium miniplate rigid fixation and intermaxillary traction titanium screw to rigidly tract the jaw during the operation. METHODS: 54 mandibular fractures in 45 patients were included in this study. After general anaesthesia, the intermaxillary traction titanium screw was inserted in the alveolar bone, between the two incisors, between the canine and the first premolar, between the first molar and the second molar, and the intermaxillary traction was finished with 0.5 mm stainless steel wire. After the mandibular arch and occlusion relationship were returned to preoperative condition, transoral mucoperiosteal incision was made to expose the fracture lines and fragments. Two 2.0 mm titanium miniplates were adapted along the Champy's line of ideal osteosynthesis and secured. After operation the stainless steel wire was released. Panoramic radiograph and clinical examination were applied at the first day and three months after operation to exhibit bone union and occlusion. RESULTS: Most patients displayed satisfied occlusion and bone union without major complications. Seventeen patients had numbness of the lower lips after operation, and the symptom was disappeared three months later. Two patients had improvement of numbness of the lower lips. CONCLUSION: Intraoral open reduction of mandibular body fracture using titanium miniplate rigid fixation and intermaxillary traction titanium screw showed high efficiency in fixation of the mandibular arch fractures , which occurred in the body and the angle of the mandible.


Assuntos
Fixação Interna de Fraturas , Fraturas Mandibulares/cirurgia , Placas Ósseas , Parafusos Ósseos , Oclusão Dentária , Humanos , Técnicas de Fixação da Arcada Osseodentária , Titânio
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...